Strategies for improving blood pressure control

American Journal of Hypertension

Volumn 11, Issue 7, 1998, Pages 897-899

  Weber, Michael A ^a  

^a BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DRUG DEVELOPMENT; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DELIVERY OF HEALTH CARE; DRUG EVALUATION; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; PATIENT COMPLIANCE; PHYSICIAN'S ROLE;

EID: 0032126241     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00081-8     Document Type: Conference Paper

References (8)

1. 1. Burt VL, Cutler JA, Higgins M: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960-1991. Hypertension 1995;26:60-69.
2. 2. Joint National Committee: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNCVI). Arch Intern Med 1997;157:2413-2446.
3. 3. Weber MA: Coronary heart disease and hypertension. Am J Hypertens 1994;7:146S-153S.
4. 4. Haynes RB, Mattson ME, Engebretson JR, for the Working Group on Patient Compliance to Prescribed Antihypertensive Medication Regimens: Patient compliance to prescribed antihypertensive medication regimens: a report to the National Heart, Lung, Blood Institute. Government Printing Office, Washington, DC, (DHHS publication No. (PHS-NIH) 81-2101), 1980.
5. 5. Dzau V, Julius S, Weber MA: ADOPT Trial results: comparison of response rates by age, race, medical history (abst). Am J Hypertens 1994;7 (4, part 2): 123A.
6. 6. Laragh JH: Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and adolesterone profiles. Am J Med 1973;55:261-274.
7. 7. Weber MA, Priest RT, Ricci BA, et al: Low-dose diuretic and a beta-adrenoceptor blocker in essential hypertension. Clin Pharmacol Ther 1980;28:149-158.
8. 8. Frishman WH, Bryzinski BS, Coulson LR: A multifactorial trial design to assess combination therapy in hypertension. Arch Intern Med 1994;154:1463.